Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins
Homologous recombination (HR) is a major pathway for the repair of DNA double-strand
breaks in mammalian cells, the defining step of which is homologous strand exchange …
breaks in mammalian cells, the defining step of which is homologous strand exchange …
Biomarkers for homologous recombination deficiency in cancer
Defective DNA repair is a common hallmark of cancer. Homologous recombination is a DNA
repair pathway of clinical interest due to the sensitivity of homologous recombination …
repair pathway of clinical interest due to the sensitivity of homologous recombination …
Identification of common genetic risk variants for autism spectrum disorder
Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of
neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic …
neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic …
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
Despite advances in biology and therapeutic modalities, existence of highly tumorigenic
glioma stem-like cells (GSCs) makes glioblastomas (GBMs) invincible. N6-methyl adenosine …
glioma stem-like cells (GSCs) makes glioblastomas (GBMs) invincible. N6-methyl adenosine …
Oncometabolites suppress DNA repair by disrupting local chromatin signalling
Deregulation of metabolism and disruption of genome integrity are hallmarks of cancer.
Increased levels of the metabolites 2-hydroxyglutarate, succinate and fumarate occur in …
Increased levels of the metabolites 2-hydroxyglutarate, succinate and fumarate occur in …
Adaptive mutability of colorectal cancers in response to targeted therapies
The emergence of drug resistance limits the efficacy of targeted therapies in human tumors.
The prevalent view is that resistance is a fait accompli: when treatment is initiated, cancers …
The prevalent view is that resistance is a fait accompli: when treatment is initiated, cancers …
Replication fork stability confers chemoresistance in BRCA-deficient cells
Cells deficient in the Brca1 and Brca2 genes have reduced capacity to repair DNA double-
strand breaks by homologous recombination and consequently are hypersensitive to DNA …
strand breaks by homologous recombination and consequently are hypersensitive to DNA …
CRISPR screens identify genomic ribonucleotides as a source of PARP-trap** lesions
The observation that BRCA1-and BRCA2-deficient cells are sensitive to inhibitors of poly
(ADP–ribose) polymerase (PARP) has spurred the development of cancer therapies that use …
(ADP–ribose) polymerase (PARP) has spurred the development of cancer therapies that use …
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
PL Sulkowski, CD Corso, ND Robinson… - Science translational …, 2017 - science.org
2-Hydroxyglutarate (2HG) exists as two enantiomers,(R)-2HG and (S)-2HG, and both are
implicated in tumor progression via their inhibitory effects on α-ketoglutarate (αKG) …
implicated in tumor progression via their inhibitory effects on α-ketoglutarate (αKG) …
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
H Xu, M Di Antonio, S McKinney, V Mathew… - Nature …, 2017 - nature.com
G-quadruplex DNAs form four-stranded helical structures and are proposed to play key roles
in different cellular processes. Targeting G-quadruplex DNAs for cancer treatment is a very …
in different cellular processes. Targeting G-quadruplex DNAs for cancer treatment is a very …